YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Enhancing Drug Safety Monitoring


May 15, 2007 | Phase Forward springs ahead with version 2.5 of the company’s Clinical Trials Signal Detection (CTSD) system, a comprehensive tool for detecting, evaluating, and tracking potential safety signals. CTSD 2.5 provides an enhanced user interface with clear summary displays, a wide selection of data visualization tools, and the ability to easily access trial data without programming. The new version also offers a user interface designed to facilitate the safety review workflow with interactive displays that include patient level drill downs, Lab Trend graphs, an Exposure Summary graph, and Kaplan Meier plots. The system is integrated with Phase Forward’s WebSDM (Web Submission Data Manager) platform, offering seamless support for the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM) data standard when submitting files to regulatory agencies. and provides a data repository.

Product: Clinical Trials Signal Detection v2.5
Company: Phase Forward
Available: Now
For More Information: www.phaseforward.com/products/safety/ctsd/

Subscribe to Bio-IT World  magazine.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.